Bollinger Band Analysis Review of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) for the period of 9-Day stands at 57.87% while the stochastic %D for the same period stands at 52.62%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) while 20-100 Day MACD Oscillator indicates “Sell”.

Bollinger band is a volatility indicator of a certain security, currently AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s 20-Day Bollinger Band indicates “Hold”.

About Company

AVEO Pharmaceuticals, Inc. is a biopharmaceutical company engaged in discovering, developing and commercializing novel cancer therapeutics. Its product candidates are targeted against important mechanisms known or believed to be involved in cancer. Tivozanib, the Company’s lead product candidate, is a highly potent and selective oral inhibitor of the vascular endothelial growth factor, or VEGF, receptors 1, 2 and 3. In addition to tivozanib, AVEO Pharmaceuticals has a pipeline of monoclonal antibodies derived from Human Response Platform (HRP), a novel method of building preclinical models of human cancer, which are intended to more accurately represent cancer biology in patients. AV-299 is the Company’s next product candidate which is an antibody that binds to hepatocyte growth factor, or HGF, thereby blocking its function. AVEO Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Previous Day Activity Analysis

On the last trading day, AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) opened the session at $3.09 and after going down -3.88% closed at $2.97. The stock lost -0.12 points in the last trade.

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s stock fluctuated in the range of $2.87 and $3.11 during the previous active session. AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) traded with the volume of 1.88 Million with average volume of 4.56 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 1.14 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.25 and 43.49 respectively.

Currently the Insider Ownership of the shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) is at 0.64% and the shares outstanding are 118.01 Million.

Important Ratio Analysis

Some important ratios to consider here for AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) are discussed below:

Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 87.62 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 9.35 and 0 correspondingly.

The Quick Ratio of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) stands at 2.3 while the Current Ratio depicts the value of 2.3.

Stock Performance Analysis

The stock performance of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) on the basis of 5 day trade show the dip of -0.67% whereas, the monthly performance of the stock shows decrease of -13.66%.

The quarterly performance of the stock remained in red zone with the value of -3.88% while six month performance of the shares of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) remained bullish with the count of 379.03%.

The yearly and YTD performance of AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO) remained up at 349.86% and 450% respectively.